Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram ...

Mean percentage predicted morning (a) and evening (b) peak expiratory flow rate (PEF) during 12 weeks of study treatment with a salmeterol/fluticasone propionate (FP) combination or budesonide in ...